A Prospective Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain

A Prospective Open Label Pilot Study Investigating the Impact of ThermaCare on Flexibility, Muscle Relaxation & Low Back Pain in Two Different Populations

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03151265

Enrollment

Registered

2017-05-12

Start date

2017-07-03

Completion date

2017-12-21

Last updated

2019-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Low Back Pain

Keywords

Functional Outcome Measures, Wearable Sensors, ViMove, Low Back Pain, Range of Movement, Muscle Activity, ThermaCare

Brief summary

The objective of this Investigator Initiated study is to evaluate the effectiveness of ThermaCare HeatWraps in improving flexibility and low back muscle relaxation, and in participants experiencing pain, reducing pain during movement. This study is an intervention trial on two discrete subject samples; (1) people with recent back pain, and (2) people who regularly play sport. ViMove wearable sensors provide precise objective measurements of low back muscle activity and movement in real time and can capture a patient's reporting of pain during movement. Outcomes will be assessed through standard ViMove protocols in conjunction with multiple validated measures of pain, perception of change, and function.

Detailed description

This investigator-initiated study will utilize a prospective open-label study design to evaluate the effectiveness of ThermaCare HeatWraps in improving flexibility and low back muscle relaxation, and in participants experiencing pain, reducing pain during movement. Two discrete subject samples will be enrolled; (1) people with recent back pain, and (2) people who regularly play sport. Both samples will be enrolled using respective criteria. Following enrollment, both subject groups will have a start interview on their allocated baseline assessment day (Day 1). This will include fitting of the ViMove movement and EMG sensors, as well as a live pain on movement assessment. This session will take approximately 20-30 minutes. Whilst wearing the ViMove sensors, subjects will then leave the clinic and conduct normal daily activities for a pre-determined monitoring period. No ThermaCare HeatWraps are worn on Day 1. This allows a baseline assessment and allows any placebo effects from the sensors to be discounted. At the end of the monitoring session, subjects will return to the clinic to have an end-of-day interview. Clinicians will administer the Oswestry Disability Index (ODI), the Visual Analogue Scale for Pain (VAS Pain), and the Patient Global Impression of Change scale (PGIC). ViMove movement sensors will then be removed, and the subject will be reimbursed for that day. The intervention day (Day 2) will have the same procedure as Day 1 (baseline), with the only difference being the additional application of ThermaCare HeatWraps during the start interview. Subjects will continue to wear the HeatWrap and ViMove sensors during the 8-hour daily activity monitoring period, with the wrap and sensors being removed during the end-of-day interview. The subject will then be reimbursed for Day 2.

Interventions

DEVICEThermaCare Low Back Heat Wrap

The ThermaCare Low Back Heat Wrap, is a continuous, low-level, direct heat therapy. It comes in the form of a heat-pack that is strapped to the low back. Heat is provided for approximately 8-hours.

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

NONE

Masking description

This study is open label, meaning that no masking occurs

Intervention model description

The two study groups (LBP group vs. Active in spot group), will receive the same intervention in the same order (i.e. Baseline day with no intervention, then intervention day with ThermaCare intervention).

Eligibility

Sex/Gender

ALL

Age

21 Years to 54 Years

Healthy volunteers

Yes

Inclusion criteria

for recent low back pain patients (Group 1): 1. Adults between the age of 21-54 inclusive, male and female. 2. Low back pain is the primary source of pain over the last 3 weeks. 3. Have experienced and received treatment for muscle related low back pain with an average score of at least 3/10 on a 10-point Numeric Rating scale over the past 3 weeks. 4. Must be able to communicate fluently in English. 5. Must provide written informed consent. 6. Must agree to confidentiality. Inclusion criteria for people who are active in sports (Group 2): 1. Adults between the age of 21-54 inclusive, male and female. 2. Participate in 30 min of moderate to high intensity exercise 3 times per week. As defined by Borg Rating of Perceived Exertion scale. 3. Must be able to communicate fluently in English. 4. Must provide written informed consent. 5. Must agree to confidentiality.

Exclusion criteria

(applies to both Groups): 1. The subject is pregnant. 2. The subject has a severe hearing impairment. 3. The subject is cognitively impaired. 4. Known allergic skin reaction to tapes and plasters. 5. Co-morbidities of neoplasm, infection, fracture, inflammatory or metabolic disorder that has potential to affect the lumbo-pelvic region. 6. Person who is currently enrolled in another investigational drug or device study.

Design outcomes

Primary

Measure	Time frame	Description
Change in Movement Data Over Time	Change from Baseline movement data after 1 consecutive day.	Collection of movement data from all participants. The results listed here depict the average change in Trunk Range of Motion (ROM) between day 1 and day 2 PM sessions
Change in Erector Spinae Muscle Activity Over Time	Change from Baseline Erector spinae muscle activity data after 1 consecutive day.	Collection of erector spinae muscle activity data from all participants. The results provided depict the mean muscle-activity difference between the day 1 and day 2 PM sessions. Surface Electromyography (sEMG) sensors are adhered utilizing a height-specific sensor placement template. Placement is parallel with the L3 vertebrae. Evaluated in the form of the flexion-relaxation response. When performing a forward flexion movement, muscle activation occurs at the commencement of the movement (when bending down;concentric), as well as during the return to the upright position (eccentric). At maximum flexion, minimal muscle activation is expected (i.e. muscle relaxation). However, in subjects with Low-back pain, muscle relaxation is often absent. As such, the following formula is used to evaluate the flexion-relaxation response. Sum of sEMG activity at maximum flexion divided by the summed sEMG activity of both concentric and eccentric muscle activation.

Secondary

Measure	Time frame	Description
A Change in Muscle Activity From Baseline in Subjects Where Abnormal EMG Activity During Baseline is Detected.	Change from Baseline after 1 consecutive day.	Surface EMG measurement of erector spinae muscle activity at L3 vertebra level
Change in Pain From Baseline	Change from Baseline after 1 consecutive day.	Pain Score out of 10 as measured on a Numeric Rating scale (NRS) Score from 0-10 where 10 indicates maximum pain, and 0 indicates no pain. The results depicted indicate the change in NRS scores between baseline and post-intervention
A Change Over Time in Range of Motion in Any One Plane of Movement Compared to Pre-intervention Range of Motion.	Change from Baseline after 1 consecutive day.	Maximal range of low back movement in sagittal,axial and coronal planes. Results depict the change in Pelvis ROM in the sagittal plane.
Impression of Change From Subjects Post Intervention and/or Assessment Period Using the Patient Global Impression of Change Scale (PGIC).	Change from Baseline after 1 consecutive day.	Measurement of perceived change in Low back pain. Score from a scale of 1-7. 1 indicates no change (or condition has worsened), 7 indicates a considerable improvement. The results depicted indicate the change in PGIC scores between Day 1 and Day 2 (intervention)
Observation of Self-reported Changes in Functional Status Pre- and Post- ThermaCare Application as Measured by the Roland Morris Disability Questionnaire (RMDQ) if Subjects Scored >3 on the NRS	Change from Baseline after 1 consecutive day.	Measurement of disability related to low back pain. A checklist of 24 items. A score of 24 indicates maximum disability.
Observation of Self-reported Changes in Functional Status Pre- and Post- ThermaCare Application as Measured by the Oswestry Disability Index (ODI) if Subjects Scored >3 on the NRS	Change from Baseline after 1 consecutive day.	Measurement of disability related to low back pain. Contains 10 sections, each of which can be from from 0-5 for a maximum score of 50. 50 indicates maximum possible disability (bed-bound - or are exaggerating their symptoms). The results depicted indicate the change in NRS scores between baseline and post-intervention
In Group 1 (LBP Patients), a Change in Maximum Pain During Movement Score, for Any One Plane of Movement.	Change from Baseline after 1 consecutive day.	Pain Score out of 10 as rated on the ViMove scale during movement assessment. Score from 0-10 where 10 indicates maximum pain, and 0 indicates no pain. The results depicted indicate the change in pain scores between baseline and post-intervention

Countries

Australia

Participant flow

Participants by arm

Arm	Count
Low Back Pain Group Low Back Pain (LBP) group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a Baseline assessment of flexibility, muscle relaxation and low back pain. The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day. ThermaCare Low Back Heat Wrap: The ThermaCare Low Back Heat Wrap, is a continuous, low-level, direct heat therapy. It comes in the form of a heat-pack that is strapped to the low back. Heat is provided for approximately 8-hours.	20
Active in Sport Group Sport group will be assessed on two consecutive days. The first day will have no ThermaCare intervention applied, and is for a baseline assessment of flexibility, muscle relaxation and low back pain. The second day will have the ThermaCare Low Back Heat Wrap intervention applied, and will have the same assessments as the Baseline day. ThermaCare Low Back Heat Wrap: The ThermaCare Low Back Heat Wrap, is a continuous, low-level, direct heat therapy. It comes in the form of a heat-pack that is strapped to the low back. Heat is provided for approximately 8-hours.	20
Total	40

Baseline characteristics

Characteristic	Active in Sport Group	Total	Low Back Pain Group
Age, Categorical <=18 years	0 Participants	0 Participants	0 Participants
Age, Categorical >=65 years	0 Participants	0 Participants	0 Participants
Age, Categorical Between 18 and 65 years	20 Participants	40 Participants	20 Participants
Race and Ethnicity Not Collected	—	0 Participants	—
Region of Enrollment Australia	20 participants	40 participants	20 participants
Sex: Female, Male Female	11 Participants	27 Participants	16 Participants
Sex: Female, Male Male	9 Participants	13 Participants	4 Participants

Adverse events

Event type	EG000 affected / at risk	EG001 affected / at risk
deaths Total, all-cause mortality	0 / 20	0 / 20
other Total, other adverse events	0 / 20	0 / 20
serious Total, serious adverse events	0 / 20	0 / 20

Outcome results

Primary

Change in Erector Spinae Muscle Activity Over Time

Collection of erector spinae muscle activity data from all participants. The results provided depict the mean muscle-activity difference between the day 1 and day 2 PM sessions. Surface Electromyography (sEMG) sensors are adhered utilizing a height-specific sensor placement template. Placement is parallel with the L3 vertebrae. Evaluated in the form of the flexion-relaxation response. When performing a forward flexion movement, muscle activation occurs at the commencement of the movement (when bending down;concentric), as well as during the return to the upright position (eccentric). At maximum flexion, minimal muscle activation is expected (i.e. muscle relaxation). However, in subjects with Low-back pain, muscle relaxation is often absent. As such, the following formula is used to evaluate the flexion-relaxation response. Sum of sEMG activity at maximum flexion divided by the summed sEMG activity of both concentric and eccentric muscle activation.

Time frame: Change from Baseline Erector spinae muscle activity data after 1 consecutive day.

Arm	Measure	Value (MEAN)	Dispersion
Low Back Pain Group	Change in Erector Spinae Muscle Activity Over Time	-.13 Ratio	Standard Deviation 0.28
Active in Sport Group	Change in Erector Spinae Muscle Activity Over Time	-.019 Ratio	Standard Deviation 0.45

Primary

Change in Movement Data Over Time

Collection of movement data from all participants. The results listed here depict the average change in Trunk Range of Motion (ROM) between day 1 and day 2 PM sessions

Time frame: Change from Baseline movement data after 1 consecutive day.

Arm	Measure	Value (MEAN)	Dispersion
Low Back Pain Group	Change in Movement Data Over Time	2.74 Degrees	Standard Deviation 6.17
Active in Sport Group	Change in Movement Data Over Time	1.1 Degrees	Standard Deviation 6.9

Secondary